The yeast non-Mendelian factor [ETA+] is a variant of [PSI+], a prion-like form of release factor eRF3

EMBO Journal

Volumn 18, Issue 5, 1999, Pages 1182-1191

  Zhou, Ping ^a   Derkatch, Irina L ^a   Uptain, Susan M ^b   Patino, Maria M ^b   Lindquist, Susan ^b   Liebman, Susan W ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Prion; Release factor; SUP35; ETA ; PSI

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN;

ARTICLE; GENETIC VARIABILITY; LETHAL MUTANT; NONHUMAN; PHENOTYPE; PRION; PRIORITY JOURNAL; RNA TRANSLATION; STOP CODON; YEAST;

EID: 0033106024     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.5.1182     Document Type: Article

References (60)

1. Aigle, M. and Lacroute, F. (1975) Genetical aspects of [URE3], a non-Mendelian, cytoplasmically inherited mutation in yeast. Mol. Gen. Genet., 136, 327-335.
2. Beggs, J.D. (1981) Multiple-copy yeast plasmid vectors. In Von Wettstein, D., Friis, J., Kielland-Bradt, M. and Stenderup, A. (eds), Molecular Genetics in Yeast. Vol. 16. Alfred Benzon Symposium, Manksgaard, Copenhagen, pp. 383-396.
3. Bonetti, B., Fu, L., Moon, J. and Bedwell, D.M. (1995) The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J. Mol. Biol., 251, 334-345.
4. Broach, J.R., Strathern, J.N. and Hicks, J.B. (1979) Transformation in yeast: Development of a hybrid cloning vector and isolation of the CAN1 gene. Gene, 8, 121-127.
5. Caughey, B. and Chesebro, B. (1997) Prion protein and the transmissible spongiform encephalopathies. Trans. Cell Biol., 7, 56-62.
6. Cesarini, G. and Murray, A.H. (1987) Plasmid vectors carrying the replication origin of filamentous single-stranded phages. In Setlow, J.K. (ed.), Genetic Engineering: Principles and Methods. Vol. 4. Plenum Press, New York, NY, pp. 135-154.
7. Chernoff, Y.O., Derkach, I.L., Dagkesamanskaya, A.R., Tikhomirova, V.L., Ter-Avanesyan, M.D. and Inge-Vechtomov, S.G. (1988) Nonsense suppression caused by the amplification of translation factor gene. Dokl. Akad. Nauk SSSR (Biol. Sci.), 301, 1227-1229.
8. Chernoff, Y.O., Inge-Vechtomov, S.G., Derkach, I.L., Ptyushkina, M.V., Tarunina, O.V., Dagkesamanskaya, A.R. and Ter-Avanesyan, M.D. (1992) Dosage-dependent translational suppression in yeast Saccharomyces cerevisiae. Yeast, 8, 489-499.
9. Chernoff, Y.O., Derkach, I.L. and Inge-Vechtomov, S.G. (1993) Multicopy SUP35 gene induces de novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet., 24, 268-270.
10. +]. Science, 268, 880-884.
11. Cohen, F.E., Pan, K.M., Huang, Z., Baldwin, M., Fletterick, R.J. and Prusiner, S.B. (1994) Structural clues to prion replication. Science, 264, 530-531.
12. Cox, B.S. (1971) A recessive lethal super-suppressor mutation in yeast and other ψ phenomena. Heredity, 26, 211-232.
13. Cox, B.S. (1977) Allosuppressors in yeast. Genet. Res., 30, 187-205.
14. Cox, B.S., Tuite, M.F. and Mclaughlin, C.S. (1988) The ψ factor of yeast: a problem in inheritance. Yeast, 4, 159-178.
15. Crouzet, M. and Tuite, M.F. (1987) Genetic control of translational fidelity in yeast: molecular cloning and analysis of the allusuppressor gene SAL3. Mol. Gen. Genet., 210, 581-583.
16. Crouzet, M., Izgu, F. and Tuite, M.F. (1988) The allosuppressor gene SAL4 encodes a protein important for maintaining translational fidelity in Saccharomyces cerevisiae. Curr. Genet., 14, 537-543.
17. Czaplinski, K., Ruiz-Echevarria, M.J., Paushkin, S.V., Han, X., Weng, Y., Perlick, H.A., Deitz, H.C., Ter-Avanesyan, M.D. and Peltz, S.W. (1998) The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev., 12, 1665-1677.
18. Dagkesamanskaya, A.R. and Ter-Avanesyan, M.D. (1991) Interaction of the yeast omnipotent suppressers SUP1 (SUP45) and SUP2 (SUP35) with non-Mendelian factors. Genetics, 128, 513-520.
19. Derkatch, I.L., Chernoff, Y.O., Kushnirov, V.V., Inge-Vechtomov, S.G. and Liebman, S.W. (1996) Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics, 144, 1375-1386.
20. +] prion in Saccharomyces cerevisiae. Genetics, 147, 507-519.
21. +] prion. Proc. Natl Acad. Sci. USA, 95, 2400-2405.
22. +] prion in yeast. Curr. Genet., in press.
23. Doel, S.M., McCready, S.J., Nierras, C.R. and Cox, B.S. (1994) The dominant PNM2-mutation which eliminates the ψ factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics, 137, 659-670.
24. Drugeon, G., Jean-Jean, O., Frolova, L., Le Goff, X., Philippe, M., Kisselev, L. and Haenni, A.L. (1997) Eukaryotic release factor 1 (eRF1) abolishes readthrough and competes with suppressor tRNAs at all three termination codons in messenger RNA. Nucleic Acids Res., 25, 2254-2258.
25. Frolova, L. et al. (1994) A highly conserved eukaryotic protein family processing properties of polypeptide chain release factor. Nature, 372, 701-703.
26. +], a heritable prion-like factor of S. cerevisiae. Cell, 89, 811-819.
27. Griffith, J.S. (1967) Self-replication and scrapie. Nature, 215, 1043-1044.
28. Hoffman, C.S. and Winston, F. (1987) A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene, 57, 267-272.
29. Ito, H., Fukuda, Y., Murata, K. and Kimura, A. (1983) Transformation of intact yeast cells treated with alkali cations. J. Bacteriol., 153, 163-168.
30. Jarret, J.T. and Lansbury, P.T. (1993) Seeding 'one dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 73, 1055-1058.
31. King, C.Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M. and Wuthrich, K. (1997) Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl Acad. Sci. USA, 94, 6618-6622.
32. +] determinant in Saccharomyces cerevisiae. Curr. Genet. 34, 146-151.
33. Kushnirov, V.V., Ter-Avanesyan, M.D., Telckov, M.V., Surguchov, A.P., Smirnov, V.N. and Inge-Vechtomov, S.G. (1988) Nucleotide sequence of the SUP2 (SUP35) gene of Saccharomyces cerevisiae. Gene, 66, 45-54.
34. Le Goff, X., Philippe, M. and Jean-Jean, O. (1997) Overexpression of human release factor 1 alone has an antisuppressor effect in human cells. Mol. Cell. Biol., 17, 3164-3172.
35. +], causes lethality of yeast omnipotent-suppressor strains. Curr. Genet., 8, 567-573.
36. Liebman, S.W. and Cavenagh, M. (1980) An antisuppressor that acts on omnipotent suppressors in yeast. Genetics, 95, 49-61.
37. +] prion: making sense of nonsense. J. Biol. Chem., 274, 1181-1184.
38. Mottagui-Tabar, S., Tuite, M.F. and Isaksson, L.A. (1998) The influence of 5′ codon context on translation termination in Saccharomyces cerevisiae. Eur. J. Biochem., 257, 249-254.
39. Patino, M.M., Liu, J.J., Glover, J.R. and Lindquist, S. (1996) Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science, 273, 622-626.
40. +] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J., 15, 3127-3134.
41. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N. and Ter-Avanesyan, M.D. (1997a) In vitro propagation of the prion-like state of yeast Sup35 protein. Science, 277, 381-383.
42. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N. and Ter-Avanesyan, M.D. (1997b) Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol. Cell. Biol., 17, 2798-2805.
43. Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science, 216, 136-144.
44. Prusiner, S.B. (1996) Molecular biology and pathogenesis of prion diseases. Trends Biochem. Sci., 21, 482-487.
45. Rose, M.D., Novick, P., Thomas, J.H., Botstein, D. and Fink, G.R. (1987) A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene. 60, 237-243.
46. Rose, M.D., Winston, F. and Heiter, P. (1990) Methods in Yeast Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Rothstein (1983) One step gene disruption in yeast. Methods Enzymol., 101, 202-211.
48. Sanger, F. Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA, 74, 5463-5467.
49. +, in yeast by hypertonic media. Proc. Natl Acad. Sci. USA, 76, 1952-1956.
50. Sherman, F. Fink, G.R. and Hicks, J.B. (1986) Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
51. Song, J.M. and Liebman, S.W. (1985) Interaction of UAG suppressors and omnipotent suppressors in Saccharomyces cerevisiae. J. Bacteriol., 161, 778-780.
52. Stansfield, I. et al. (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J., 14, 4365-4373.
53. Ter-Avanesyan, M.D., Kushnirov, V.V., Dagkesamanskaya, A.R., Didichenko, S.A., Chernoff, Y.O., Inge-Vechtomov, S.G. and Smirnov, V.N. (1993) Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol., 7, 683-692.
54. +] in the yeast Saccharomyces cerevisiae. Genetics, 137, 671-676.
55. -] in Saccharomyces cerevisiae. Genetics, 98, 691-711.
56. Weissmann, C. (1999) Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem., 274, 3-6.
57. Wickner, R.B. (1994) [URE3] as an altered Ure2 protein: evidente for prion analogue in Saccharomyces cerevisiae. Science, 264, 566-569.
58. Wickner, R.B., Masison, D.C. and Edskes, H.K. (1996) [URE3] and [PSI] as prions of Saccharomyces cerevisiae: genetic evidence and biochemical properties. Semin. Virol., 7, 215-233.
59. Wilson, P.G. and Culbertson, M.R. (1988) SUP12 suppressor protein of yeast. A fusion protein related to the EF-1 family of elongation factors. J. Mol. Biol., 199, 559-573.
60. Zhouravleva, G., Frolova, L., Le Goff, X., Le Guellec, R., Inge-Vechtomov, S.G., Kisselev, L. and Philippe, M. (1995) Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J., 14, 4065-4072.